Review Article
Chinese Herbal Medicine for the Treatment of Prehypertension
Table 1
Characteristics and methodological quality of included studies.
| Study ID | Sample | Diagnosis standard | Intervention | Control | Course (week) | Outcome measure |
| Yang 2011 [45] | 90 | JNC-7; GCRNDTCM | CHM (800 mL/d#) + control | Life style intervention | 4 | BP | Li 2010 [46] | 80 | JNC-7; GCRNDTCM | BBTD (400 mL/d#) + control | Life style intervention | 4 | BP | Li et al. 2011 [47] | 123 | JNC-7; TCM diagnostic criteria (unclear) | RQSPD (200 mL/d#) | No treatment | 4 | BP | Wu and Ding 2011 [48] | 80 | JNC-7; GCRNDTCM | TPKP (1.2 g tid) + control | Life style intervention | 8 | BP | Zhang 2012 [49] | 57 | JNC-7; TCM diagnostic criteria (unclear) | BPLLD (1 bag bid) | Life style intervention | 12 | BP |
|
|
Note: CHM: Chinese herb medicine; BBTD: Banxia baizhu tianma decoction; RQSPD: replenishing qi and strengthening spleen decoction; TPKP: tiao ping kang pill; BPLLD: blood pressure-lipid lowering decoction.
|